Citation 77204

AQUINO,R: PELUSO,G: DE TOMMASI,N: DE SIMONE,F: PIZZA,C:. (1996). NEW POLYOXYPREGNANE ESTER DERIVATIVES FROM LEPTADENIA HASTATA.. 59(6)

Citation Details

TitleNEW POLYOXYPREGNANE ESTER DERIVATIVES FROM LEPTADENIA HASTATA.
AuthorsAQUINO,R: PELUSO,G: DE TOMMASI,N: DE SIMONE,F: PIZZA,C:
Year1996
Volume59
Issue6

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Leptadenia hastata (ASCLEPIADACEAE)

Experiment #Pharmacology TypeWorktypesCompoundResults
1Not specified
VOUCHER SPECIMEN REPORTED FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,20-O-BENZOYL-12-O-CINNAMOYL:
None
2Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
GAGAMININ,ISO:
None
3Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-20-DI-O-ACETYL:
None
4Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PENUPOGENIN-3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
5Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL-(1-4)-BETA-D-CYMAROPYRANOSIDE
None
6Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PENUPOGENIN-3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
7Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
8Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-20-DI-O-BENZOYL: 3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
9Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,20-O-ACETYL-12-O-CINNAMOYL: 3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANSOYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
10Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-BENZOYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
11Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,20-O-ACETYL-12-O-NICOTINOYL,3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
12Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
METAPLEXIGENIN-3-O-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
13Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CYNANFORDIN-3-O-BETA-D-OLEANDROPYRANOSYL(14)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMPAROPYRANOSIDE
None
14Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRNAOSYL(1-4)-BETA-D-OLEANDROPYRANSOYL(1-4)-BETA-D-CYMAROPYRNAOSIDE
None
15Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-20-O-DIBENZOYL: 3-O-BETA-6-DEXOY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
16Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-CINNAMOYL-20-O-NICOTINOYL,3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
17Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CYANFORIDIN-3-O-BETA-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-CYMANOPYRANOSIDE
None
18Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
METAPLEXIGENIN,12-O-NICOTINOYL-DEACETYL,3-O-BETA-D-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
19Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-CINNAMOYL-20-META-HYDROXY-BENZOYL: 3-O-BETA-D-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRNAOSIDE
None
20Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,20-O-ACETYL-12-O-NICOTINOYL,3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
21Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PENUPOGENIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
22Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
CYANFORIDIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
23Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
METAPLEXIGENIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANSOYL(1-4)-BETA-D-OLEANDROPYRNAOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
24Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
KIDJOLANIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRNAOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
25Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,17-O-ACETYL-20-O-CINNAMOYL-12-O-NICOTINOYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
26Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PENUPOGENIN-3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
27Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-D-GLUCOPYRANSOYL(1-4)-BETA-D-THEVETOPYRANSOYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
28
DNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-D-GLUCOPYRANSOYL(1-4)-BETA-D-THEVETOPYRANSOYL(1-4)-BETA-D-CYMAROPYRANOSIDE
ACTIVE
29
CELL CYCLE CYTOTOXICITY(G1 PHASE)
PHARMACOLOGY OF COMPOUND - IN VITRO
SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL: 3-O-BETA-D-GLUCOPYRANSOYL(1-4)-BETA-D-THEVETOPYRANSOYL(1-4)-BETA-D-CYMAROPYRANOSIDE
ACTIVE
30Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-BENZOYL-20-O-CINNAMOYL,3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
31Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,20-O-BENZOYL-12-O-CINNAOMOYL: 3-O-BETA-D-GLUCOPYRNOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRNOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
32Not specified
QUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
KIDJOLANIN-3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
33Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
PENUPOGENIN-3-O-BETA-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMOROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
34
DNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
PENUPOGENIN-3-O-BETA-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMOROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
WEAK ACTIVITY
35
CELL CYCLE CYTOTOXICITY(G1 PHASE)
PHARMACOLOGY OF COMPOUND - IN VITRO
PENUPOGENIN-3-O-BETA-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMOROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
WEAK ACTIVITY
36Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
37
DNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
INACTIVE
38
CELL CYCLE CYTOTOXICITY(G1 PHASE)
PHARMACOLOGY OF COMPOUND - IN VITRO
SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
WEAK ACTIVITY
39Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
METAPLEXIGENIN-3-O-BETA-D-ALLOPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
40Not specified
MASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE
SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANSOYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
None
41
DNA SYNTHESIS INHIBITION
PHARMACOLOGY OF COMPOUND - IN VITRO
SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANSOYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
INACTIVE
42
CELL CYCLE CYTOTOXICITY(G1 PHASE)
PHARMACOLOGY OF COMPOUND - IN VITRO
SARCOSTIN,12-O-ACETYL: 3-O-BETA-D-GLUCOPYRANOSYL(1-4)-6-DEOXY-3-O-METHYL-BETA-D-ALLOPYRANSOYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-OLEANDROPYRANOSYL(1-4)-BETA-D-CYMAROPYRANOSIDE
WEAK ACTIVITY
Show SPARQL Queries (1)